Arezoo Taheri, MD
Gastroenterology · Fargo, NDNPI 1215917992
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Pfizer accounts for 98.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $19,400 and has fallen 99.9% since, to $20 in 2021. Among gastroenterology clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $514.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$28K
- Takeda Pharmaceuticals U.S.A., Inc.$223
- Intercept Pharmaceuticals, Inc.$37
- Johnson & Johnson$30
- AbbVie$14
Across 56 payments — averaging $3203.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$177K
- Janssen Research & Development, LLC$2K
What the payments were for
- Consulting fees$3,75013%
- Speaking & faculty fees$15,65055%
- Travel & lodging$7,86828%
- Food & beverage$1,0414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 36 | $28,004 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $223 |
| Intercept Pharmaceuticals, Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $30 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XELJANZ$27,536
How this compares
$28,309 in reported general payments places this provider in the 95th percentile of 26 gastroenterology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 84 | $5,286 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 185 | $2,799 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 126 | $2,020 |
| Pantoprazole Sodium | 87 | $575 |
| Omeprazole | 18 | $253 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Fargo
- Israr SheikhFargo$5K
- Fadel NammourFargo$3K
- Surianarayanan KarthikeyanFargo$3K
- Kimberly KolkhorstFargo$947
- Ross MeidingerFargo$887
- Emuejevoke OkohFargo$772
- Navin PaulFargo$743
- Settihalli RajenderFargo$397
- Steven PletcherFargo$323
- Syed ZaidiBismarck$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.